ReP USP - Resultado da busca

Artigo de periodico
Perfluorooctanoate (PFOA) cell-autonomously promotes thermogenic and adipogenic differentiation of brown and white adipocytes (2024)
Reckziegel, Patricia ; Petrovic, Natasa ; Cannon, Barbara; Nedergaard, Jan
Source: Ecotoxicology and Environmental Safety. Unidade: FCF
Subjects: TERMOGÊNESE, POLUIÇÃO AMBIENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RECKZIEGEL, Patricia et al. Perfluorooctanoate (PFOA) cell-autonomously promotes thermogenic and adipogenic differentiation of brown and white adipocytes. Ecotoxicology and Environmental Safety, v. 271, p. 1-12 art. 115955, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ecoenv.2024.115955. Acesso em: 17 nov. 2024.
APA
Reckziegel, P., Petrovic, N., Cannon, B., & Nedergaard, J. (2024). Perfluorooctanoate (PFOA) cell-autonomously promotes thermogenic and adipogenic differentiation of brown and white adipocytes. Ecotoxicology and Environmental Safety, 271, 1-12 art. 115955. doi:10.1016/j.ecoenv.2024.115955
NLM
Reckziegel P, Petrovic N, Cannon B, Nedergaard J. Perfluorooctanoate (PFOA) cell-autonomously promotes thermogenic and adipogenic differentiation of brown and white adipocytes [Internet]. Ecotoxicology and Environmental Safety. 2024 ; 271 1-12 art. 115955.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.1016/j.ecoenv.2024.115955
Vancouver
Reckziegel P, Petrovic N, Cannon B, Nedergaard J. Perfluorooctanoate (PFOA) cell-autonomously promotes thermogenic and adipogenic differentiation of brown and white adipocytes [Internet]. Ecotoxicology and Environmental Safety. 2024 ; 271 1-12 art. 115955.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.1016/j.ecoenv.2024.115955
Artigo de periodico
Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon (2024)
Alabi, Ayodele; Kokou, Kossiwa; Mahmoudou, Saidou; Kavishna, Ranmali; Nakka, Sravya S; Rothenberger, Sylvia; Musangomunei, Fungai P; Olubiyi, Bisola F; Bie-Ondo, Juste C; Kabwende, Anita L; Velavan, Thirumalaisamy P; Medaglini, Donata ; Nakaya, Helder Takashi Imoto ; Engler, Olivier; Harandi, Ali M; Siegrist, Claire Anne ; Kremsner, Peter G; Agnandji, Selidji T
Source: Journal of Infection. Unidade: FCF
Subjects: VACINAS VIRAIS, VÍRUS EBOLA, ANTICORPOS, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALABI, Ayodele et al. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon. Journal of Infection, v. 89, n. 4, p. 1-33 art. 106237, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jinf.2024.106237. Acesso em: 17 nov. 2024.
APA
Alabi, A., Kokou, K., Mahmoudou, S., Kavishna, R., Nakka, S. S., Rothenberger, S., et al. (2024). Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon. Journal of Infection, 89( 4), 1-33 art. 106237. doi:10.1016/j.jinf.2024.106237
NLM
Alabi A, Kokou K, Mahmoudou S, Kavishna R, Nakka SS, Rothenberger S, Musangomunei FP, Olubiyi BF, Bie-Ondo JC, Kabwende AL, Velavan TP, Medaglini D, Nakaya HTI, Engler O, Harandi AM, Siegrist CA, Kremsner PG, Agnandji ST. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon [Internet]. Journal of Infection. 2024 ; 89( 4): 1-33 art. 106237.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.1016/j.jinf.2024.106237
Vancouver
Alabi A, Kokou K, Mahmoudou S, Kavishna R, Nakka SS, Rothenberger S, Musangomunei FP, Olubiyi BF, Bie-Ondo JC, Kabwende AL, Velavan TP, Medaglini D, Nakaya HTI, Engler O, Harandi AM, Siegrist CA, Kremsner PG, Agnandji ST. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub- Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon [Internet]. Journal of Infection. 2024 ; 89( 4): 1-33 art. 106237.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.1016/j.jinf.2024.106237
Artigo de periodico
Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid (2024)
Zahm, Shelia ; Bonde, Jens Peter ; Chiu, Weihsueh A ; Hoppin, Jane ; Kanno, Jun ; Abdallah, Mohamed; Blystone, Chad R ; Calkins, Miriam M ; Dong, Guang Hui ; Dorman, David C; Fry, Rebecca; Guo, Huan; Haug, Line Småstuen ; Hofmann, Jonathan N. ; Iwasaki, Motoki; Machala, Miroslav ; Mancini, Francesca Romana ; Maria-Engler, Silvya Stuchi ; Møller, Peter Rsak ; Ng, Jack Chakmeng; Pallardy, Marc ; Post, Gloria B ; Salihovic, Samira ; Schlezinger, Jennifer ; Soshilov, Anatoly; Steenland, Kyle ; Steffensen, Inger Lise ; Tryndyak, Volodymyr ; White, Alexandra; Woskie, Susan
Source: The Lancet Oncology. Unidade: FCF
Subjects: CARCINOGÊNESE, PRODUTOS QUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAHM, Shelia et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, v. 25, n. 1, p. 16-17, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/S1470-2045(23)00622-8. Acesso em: 17 nov. 2024.
APA
Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, 25( 1), 16-17. doi:10.1016/S1470-2045(23)00622-8
NLM
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8
Vancouver
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8
Artigo de periodico
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts (2023)
Carvalho, Patrícia Conceição Gonzalez Dias; Hirata, Thiago Dominguez Crespo ; Alves, Leandro Yukio Mano ; Moscardini, Isabelle Franco; Nascimento, Ana Paula Barbosa do; Martins, André Guilherme Costa ; Sorgi, Sara; Harandi, Ali M; Ferreira, Daniela M ; Vianello, Eleonora ; Haks, Marielle C ; Ottenhoff, Tom H. M; Santoro, Francesco ; Murillo, Paola Martinez; Huttner, Angela; Siegrist, Claire Anne ; Medaglini, Donata ; Nakaya, Helder Takashi Imoto
Source: Frontiers in Immunology. Unidade: FCF
Subjects: GENÉTICA, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Patrícia Conceição Gonzalez Dias et al. Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts. Frontiers in Immunology, v. 14, p. 1-10 art. 1259197, 2023Tradução . . Disponível em: https://dx.doi.org/10.3389/fimmu.2023.1259197. Acesso em: 17 nov. 2024.
APA
Carvalho, P. C. G. D., Hirata, T. D. C., Alves, L. Y. M., Moscardini, I. F., Nascimento, A. P. B. do, Martins, A. G. C., et al. (2023). Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts. Frontiers in Immunology, 14, 1-10 art. 1259197. doi:10.3389/fimmu.2023.1259197
NLM
Carvalho PCGD, Hirata TDC, Alves LYM, Moscardini IF, Nascimento APB do, Martins AGC, Sorgi S, Harandi AM, Ferreira DM, Vianello E, Haks MC, Ottenhoff THM, Santoro F, Murillo PM, Huttner A, Siegrist CA, Medaglini D, Nakaya HTI. Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts [Internet]. Frontiers in Immunology. 2023 ; 14 1-10 art. 1259197.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.3389/fimmu.2023.1259197
Vancouver
Carvalho PCGD, Hirata TDC, Alves LYM, Moscardini IF, Nascimento APB do, Martins AGC, Sorgi S, Harandi AM, Ferreira DM, Vianello E, Haks MC, Ottenhoff THM, Santoro F, Murillo PM, Huttner A, Siegrist CA, Medaglini D, Nakaya HTI. Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts [Internet]. Frontiers in Immunology. 2023 ; 14 1-10 art. 1259197.[citado 2024 nov. 17 ] Available from: https://dx.doi.org/10.3389/fimmu.2023.1259197
Artigo de periodico
Resolving taxonomic confusion: establishing the genus Phytobacter on the list of clinically relevant Enterobacteriaceae (2022)
Smits, Theo H. M ; Arend, Lavinia N. V. S ; Cardew, Sofia; Hallbäck, Erika Tång ; Mira, Marcelo T ; Moore, Edward R. B ; Sampaio, Jorge Luiz Mello ; Rezzonico, Fabio ; Pillonetto, Marcelo
Source: European Journal of Clinical Microbiology & Infectious Diseases. Unidade: FCF
Subjects: ENTEROBACTERIACEAE, GENÔMICA, GENÔMICA, ZOOLOGIA (CLASSIFICAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMITS, Theo H. M et al. Resolving taxonomic confusion: establishing the genus Phytobacter on the list of clinically relevant Enterobacteriaceae. European Journal of Clinical Microbiology & Infectious Diseases, v. 41, p. 547–558, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10096-022-04413-8. Acesso em: 17 nov. 2024.
APA
Smits, T. H. M., Arend, L. N. V. S., Cardew, S., Hallbäck, E. T., Mira, M. T., Moore, E. R. B., et al. (2022). Resolving taxonomic confusion: establishing the genus Phytobacter on the list of clinically relevant Enterobacteriaceae. European Journal of Clinical Microbiology & Infectious Diseases, 41, 547–558. doi:10.1007/s10096-022-04413-8
NLM
Smits THM, Arend LNVS, Cardew S, Hallbäck ET, Mira MT, Moore ERB, Sampaio JLM, Rezzonico F, Pillonetto M. Resolving taxonomic confusion: establishing the genus Phytobacter on the list of clinically relevant Enterobacteriaceae [Internet]. European Journal of Clinical Microbiology & Infectious Diseases. 2022 ; 41 547–558.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s10096-022-04413-8
Vancouver
Smits THM, Arend LNVS, Cardew S, Hallbäck ET, Mira MT, Moore ERB, Sampaio JLM, Rezzonico F, Pillonetto M. Resolving taxonomic confusion: establishing the genus Phytobacter on the list of clinically relevant Enterobacteriaceae [Internet]. European Journal of Clinical Microbiology & Infectious Diseases. 2022 ; 41 547–558.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s10096-022-04413-8
Artigo de periodico
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts (2022)
Hernandez, Carolina Dagli ; Zhou, Yitian; Lauschke, Volker Martin; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacological Reports. Unidade: FCF
Subjects: ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, v. 74, p. 47–66, 2022Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00319-y. Acesso em: 17 nov. 2024.
APA
Hernandez, C. D., Zhou, Y., Lauschke, V. M., Genvigir, F. D. V., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2022). Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, 74, 47–66. doi:10.1007/s43440-021-00319-y
NLM
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Vancouver
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Artigo de periodico
Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model (2022)
Arora, Aastha ; Tripodi, Gustavo Luis; Kareinen, Ilona ; Berg, Martin; Forteza, Maria Josefa ; Gisterå, Anton ; Griepke, Silke; Casagrande, Felipe Beccaria ; Martins, Joilson de Oliveira ; Abdalla, Dulcinéia Saes Parra ; Cole, Jennifer ; Monaco, Claudia ; Ketelhuth, Daniel Francisco Jacon
Source: Intional Journal of Molecular Sciences. Unidade: FCF
Subjects: ARTERIOSCLEROSE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARORA, Aastha et al. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model. Intional Journal of Molecular Sciences, v. 23, p. 1-17 art. 5203, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23095203. Acesso em: 17 nov. 2024.
APA
Arora, A., Tripodi, G. L., Kareinen, I., Berg, M., Forteza, M. J., Gisterå, A., et al. (2022). Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model. Intional Journal of Molecular Sciences, 23, 1-17 art. 5203. doi:10.3390/ijms23095203
NLM
Arora A, Tripodi GL, Kareinen I, Berg M, Forteza MJ, Gisterå A, Griepke S, Casagrande FB, Martins J de O, Abdalla DSP, Cole J, Monaco C, Ketelhuth DFJ. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model [Internet]. Intional Journal of Molecular Sciences. 2022 ; 23 1-17 art. 5203.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/ijms23095203
Vancouver
Arora A, Tripodi GL, Kareinen I, Berg M, Forteza MJ, Gisterå A, Griepke S, Casagrande FB, Martins J de O, Abdalla DSP, Cole J, Monaco C, Ketelhuth DFJ. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model [Internet]. Intional Journal of Molecular Sciences. 2022 ; 23 1-17 art. 5203.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/ijms23095203
Artigo de periodico
Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia (2022)
Hernandez, Carolina Dagli ; Borges, Jéssica Bassani ; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de ; Mori, Augusto Akira ; Gonçalves, Rodrigo Marques; Faludi, André Arpad ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Bastos, Gisele Medeiros ; Zhou, Yitian ; Lauschke, Volker Martin ; Cerda, Alvaro ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmaceutics. Unidade: FCF
Subjects: HIPERCOLESTEROLEMIA, ESTATINAS, VARIAÇÃO GENÉTICA, FARMACOGENÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, v. 14, p. 1-20 art. 944, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050944. Acesso em: 17 nov. 2024.
APA
Hernandez, C. D., Borges, J. B., Marçal, E. da S. R., Freitas, R. C. C. de, Mori, A. A., Gonçalves, R. M., et al. (2022). Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, 14, 1-20 art. 944. doi:10.3390/pharmaceutics14050944
NLM
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Vancouver
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Artigo de periodico
Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients (2021)
Hirata, Thiago Dominguez Crespo ; Hernandez, Carolina Dagli ; Genvigir, Fabiana Dalla Vecchia ; Lauschke, Volker Martin ; Zhou, Yitian ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Molecular Diagnosis and Therapy. Unidade: FCF
Subjects: ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Thiago Dominguez Crespo et al. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, v. 25, p. 735–755, 2021Tradução . . Disponível em: https://doi.org/10.1007/s40291-021-00549-z. Acesso em: 17 nov. 2024.
APA
Hirata, T. D. C., Hernandez, C. D., Genvigir, F. D. V., Lauschke, V. M., Zhou, Y., Hirata, M. H., & Hirata, R. D. C. (2021). Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, 25, 735–755. doi:10.1007/s40291-021-00549-z
NLM
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Vancouver
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Artigo de periodico
XPR1 mediates the pancreatic β-Cell phosphate flush (2021)
Barker, Christopher J; Tessaro, Fernando Henrique Galvão; Ferreira, Sabrina de Souza; Simas, Rafael; Ayala, Thais S; Köhler, Martin; Rajasekaran, Subu Surendran; Martins, Joilson de Oliveira ; Darè, Elisabetta; Berggren, Per-Olof
Source: Diabetes. Unidade: FCF
Subjects: INSULINA, FOSFATOS, CÉLULAS, ILHOTAS DE LANGERHANS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARKER, Christopher J et al. XPR1 mediates the pancreatic β-Cell phosphate flush. Diabetes, v. 70, n. 1, p. 111–118, 2021Tradução . . Disponível em: https://doi.org/10.2337/db19-0633. Acesso em: 17 nov. 2024.
APA
Barker, C. J., Tessaro, F. H. G., Ferreira, S. de S., Simas, R., Ayala, T. S., Köhler, M., et al. (2021). XPR1 mediates the pancreatic β-Cell phosphate flush. Diabetes, 70( 1), 111–118. doi:10.2337/db19-0633
NLM
Barker CJ, Tessaro FHG, Ferreira S de S, Simas R, Ayala TS, Köhler M, Rajasekaran SS, Martins J de O, Darè E, Berggren P-O. XPR1 mediates the pancreatic β-Cell phosphate flush [Internet]. Diabetes. 2021 ; 70( 1): 111–118.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2337/db19-0633
Vancouver
Barker CJ, Tessaro FHG, Ferreira S de S, Simas R, Ayala TS, Köhler M, Rajasekaran SS, Martins J de O, Darè E, Berggren P-O. XPR1 mediates the pancreatic β-Cell phosphate flush [Internet]. Diabetes. 2021 ; 70( 1): 111–118.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2337/db19-0633
Artigo de periodico
Proinflammatory action of a new electronegative low-density lipoprotein epitope (2019)
Faulin, Tanize do Espírito Santo; Kazuma, Soraya Megumi; Tripodi, Gustavo Luis; Cavalcante, Marcela Frota; Wakasuqui, Felipe; Oliveira, Cristiano Luis Pinto de; Degenhardt, Maximilia Frazão de Souza; Michaloski, Jussara; Giordano, Ricardo José ; Ketelhuth, Daniel Francisco Jacon; Abdalla, Dulcinéia Saes Parra
Source: Biomolecules. Unidades: IF, IQ, FCF
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAULIN, Tanize do Espírito Santo et al. Proinflammatory action of a new electronegative low-density lipoprotein epitope. Biomolecules, v. 9, n. 8, p. 1-17 art. 386, 2019Tradução . . Disponível em: https://doi.org/10.3390/biom9080386. Acesso em: 17 nov. 2024.
APA
Faulin, T. do E. S., Kazuma, S. M., Tripodi, G. L., Cavalcante, M. F., Wakasuqui, F., Oliveira, C. L. P. de, et al. (2019). Proinflammatory action of a new electronegative low-density lipoprotein epitope. Biomolecules, 9( 8), 1-17 art. 386. doi:10.3390/biom9080386
NLM
Faulin T do ES, Kazuma SM, Tripodi GL, Cavalcante MF, Wakasuqui F, Oliveira CLP de, Degenhardt MF de S, Michaloski J, Giordano RJ, Ketelhuth DFJ, Abdalla DSP. Proinflammatory action of a new electronegative low-density lipoprotein epitope [Internet]. Biomolecules. 2019 ; 9( 8): 1-17 art. 386.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/biom9080386
Vancouver
Faulin T do ES, Kazuma SM, Tripodi GL, Cavalcante MF, Wakasuqui F, Oliveira CLP de, Degenhardt MF de S, Michaloski J, Giordano RJ, Ketelhuth DFJ, Abdalla DSP. Proinflammatory action of a new electronegative low-density lipoprotein epitope [Internet]. Biomolecules. 2019 ; 9( 8): 1-17 art. 386.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/biom9080386
Artigo de periodico
Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity (2018)
Rajasekaran, Subu Surendran; Illies, Christopher; Shears, Stephen B; Wang, Huanchen; Ayala, Thais S; Martins, Joilson de Oliveira ; Daré, Elisabetta; Berggren, Per-Olof; Barker, Christopher J
Source: Cellular Signalling. Unidade: FCF
Subjects: PROTEÍNAS QUINASES, LIPASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAJASEKARAN, Subu Surendran et al. Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity. Cellular Signalling, v. 42, p. 127-133, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cellsig.2017.10.008. Acesso em: 17 nov. 2024.
APA
Rajasekaran, S. S., Illies, C., Shears, S. B., Wang, H., Ayala, T. S., Martins, J. de O., et al. (2018). Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity. Cellular Signalling, 42, 127-133. doi:10.1016/j.cellsig.2017.10.008
NLM
Rajasekaran SS, Illies C, Shears SB, Wang H, Ayala TS, Martins J de O, Daré E, Berggren P-O, Barker CJ. Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity [Internet]. Cellular Signalling. 2018 ; 42 127-133.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.cellsig.2017.10.008
Vancouver
Rajasekaran SS, Illies C, Shears SB, Wang H, Ayala TS, Martins J de O, Daré E, Berggren P-O, Barker CJ. Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity [Internet]. Cellular Signalling. 2018 ; 42 127-133.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.cellsig.2017.10.008
Artigo de periodico
Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells (2018)
Rajasekaran, Subu Surendran; Kim, Jaeyoon; Gaboardi, Gian Carlo; Gromada, Jesper; Shears, Stephen B; Santos, Karen Tiago dos; Nolasco, Eduardo Lima; Ferreira, Sabrina de Souza; Illies, Christopher; Köhler, Martin; Gu, Chunfang; Ryu, Sung Ho; Martins, Joilson de Oliveira ; Daré, Elisabetta; Barker, Christopher J; Berggren, Per Olof
Source: Cellular Signalling. Unidade: FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAJASEKARAN, Subu Surendran et al. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells. Cellular Signalling, v. 46, p. 120-128, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cellsig.2018.03.001. Acesso em: 17 nov. 2024.
APA
Rajasekaran, S. S., Kim, J., Gaboardi, G. C., Gromada, J., Shears, S. B., Santos, K. T. dos, et al. (2018). Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells. Cellular Signalling, 46, 120-128. doi:10.1016/j.cellsig.2018.03.001
NLM
Rajasekaran SS, Kim J, Gaboardi GC, Gromada J, Shears SB, Santos KT dos, Nolasco EL, Ferreira S de S, Illies C, Köhler M, Gu C, Ryu SH, Martins J de O, Daré E, Barker CJ, Berggren PO. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells [Internet]. Cellular Signalling. 2018 ; 46 120-128.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.cellsig.2018.03.001
Vancouver
Rajasekaran SS, Kim J, Gaboardi GC, Gromada J, Shears SB, Santos KT dos, Nolasco EL, Ferreira S de S, Illies C, Köhler M, Gu C, Ryu SH, Martins J de O, Daré E, Barker CJ, Berggren PO. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells [Internet]. Cellular Signalling. 2018 ; 46 120-128.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.cellsig.2018.03.001
Artigo de periodico
Adverse Effects of Plant Food Supplements and Plants Consumed as Food: results from the Poisons Centres-Based PlantLIBRA Study (2016)
Lüde, Saskia; Vecchio, Sarah; Tellier, Sandra Sinno; Dopter, Aymeric; Mustonen, Harriet; Vucinic, Slavica; Jonsson, Birgitta; Müller, Dieter; Fruchtengarten, Ligia Veras Gimenez; Hruby, Karl; Nascimento, Elizabeth de Souza; Di Lorenzo, Chiara; Restani, Patrizia; Kupferschmidt, Hugo; Ceschi, Alessandro
Source: Phytotherapy Research. Unidade: FCF
Subjects: SUPLEMENTAÇÃO ALIMENTAR, PLANTAS ALIMENTÍCIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LÜDE, Saskia et al. Adverse Effects of Plant Food Supplements and Plants Consumed as Food: results from the Poisons Centres-Based PlantLIBRA Study. Phytotherapy Research, v. 30, n. 6, p. 988 -996, 2016Tradução . . Disponível em: https://doi.org/10.1002/ptr.5604. Acesso em: 17 nov. 2024.
APA
Lüde, S., Vecchio, S., Tellier, S. S., Dopter, A., Mustonen, H., Vucinic, S., et al. (2016). Adverse Effects of Plant Food Supplements and Plants Consumed as Food: results from the Poisons Centres-Based PlantLIBRA Study. Phytotherapy Research, 30( 6), 988 -996. doi:10.1002/ptr.5604
NLM
Lüde S, Vecchio S, Tellier SS, Dopter A, Mustonen H, Vucinic S, Jonsson B, Müller D, Fruchtengarten LVG, Hruby K, Nascimento E de S, Di Lorenzo C, Restani P, Kupferschmidt H, Ceschi A. Adverse Effects of Plant Food Supplements and Plants Consumed as Food: results from the Poisons Centres-Based PlantLIBRA Study [Internet]. Phytotherapy Research. 2016 ; 30( 6): 988 -996.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/ptr.5604
Vancouver
Lüde S, Vecchio S, Tellier SS, Dopter A, Mustonen H, Vucinic S, Jonsson B, Müller D, Fruchtengarten LVG, Hruby K, Nascimento E de S, Di Lorenzo C, Restani P, Kupferschmidt H, Ceschi A. Adverse Effects of Plant Food Supplements and Plants Consumed as Food: results from the Poisons Centres-Based PlantLIBRA Study [Internet]. Phytotherapy Research. 2016 ; 30( 6): 988 -996.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/ptr.5604

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration